ROIX Stock - Response Oncology, Inc.
Unlock GoAI Insights for ROIX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
Response Oncology, Inc. does not have significant operations. The company, along its wholly owned and majority owned subsidiaries, operated as a comprehensive cancer management company. As of May 20, 2002, the company has liquidated substantially all of its operating assets and anticipates that the remaining assets would be liquidated and all wind-down activities completed by the end of 2002. Prior to the sale of its assets, it provided: advanced cancer treatment services through outpatient facilities known as IMPACT Centers under the direction of practicing oncologists; owned the assets of and managed the nonmedical aspects of oncology practices; compounded and dispensed pharmaceuticals to certain oncologists for a fixed or cost plus fee; and conducted outcomes research on behalf of pharmaceutical manufacturers. The company was incorporated in 1984 and is based in Memphis, Tennessee.
Earnings History & Surprises
ROIXLatest News
Frequently Asked Questions about ROIX
What is ROIX's current stock price?
What is the analyst price target for ROIX?
What sector is Response Oncology, Inc. in?
What is ROIX's market cap?
Does ROIX pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to ROIX for comparison